phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide has been researched along with oxidopamine in 1 studies
Studies (phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide) | Trials (phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide) | Recent Studies (post-2010) (phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide) | Studies (oxidopamine) | Trials (oxidopamine) | Recent Studies (post-2010) (oxidopamine) |
---|---|---|---|---|---|
276 | 0 | 55 | 8,630 | 6 | 2,407 |
Protein | Taxonomy | phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide (IC50) | oxidopamine (IC50) |
---|---|---|---|
Glyceraldehyde-3-phosphate dehydrogenase | Homo sapiens (human) | 8 | |
DNA repair protein RAD52 homolog | Homo sapiens (human) | 0.779 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Allard, M; Le Moal, M; Marco, N; Simonnet, G; Stinus, L | 1 |
1 other study(ies) available for phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide and oxidopamine
Article | Year |
---|---|
Neuropeptide FLFQRFamide receptors within the ventral mesenchephalon and dopaminergic terminal areas: localization and functional antiopioid involvement.
Topics: Animals; Autoradiography; Dopamine; Immunohistochemistry; Male; Mesencephalon; Morphine; Neuropeptides; Oligopeptides; Oxidopamine; Rats; Receptors, Neuropeptide; Receptors, Opioid | 1995 |